Cite
HARVARD Citation
Maréchal, C. et al. (2019). Corrigendum to 'Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50 years of age: A randomized trial' [Vaccine 36 (2018) 4278–4286]. Vaccine. 37 (9), pp. 1252-1253. [Online].